Epinephrine
- Product NDC
- 70518-1215
- Requested package NDC
- 70518-1215-0
- 11-digit product format
- 705181215
- Labeler code
- 70518
- Product ID
- 70518-1215_d9171343-f5a0-1663-e053-2995a90a4b3e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Epinephrine
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- REMEDYREPACK INC.
- Application
- NDA205029
- Marketing category
- NDA
- Marketing start
- 2018-05-17
- Marketing end
- 0000-00-00
- Substance
- EPINEPHRINE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70518-1215 | 70518-1215-0 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 70518-1215 | 70518-1215-0 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N205029-001 | EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 |
| N205029-002 | EPINEPHRINE | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 |
| N205029-003 | EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | |
| N205029-004 | EPINEPHRINE | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-02-14 |
| N205029-005 | EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-03-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N205029-001 | AP |
| N205029-002 | AP |
| N205029-004 | AP |
| N205029-005 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-02-14 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-03-04 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-02-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-02-14 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2022-02-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2022-02-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N205029-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-004 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-005 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-004 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-004 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | AP | 1 | 2680178bc6a6… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205029-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205029-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205029-004 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205029-005 | AP | 1 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | d06236e962d9… |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-1215 | EPINEPHRINE INJECTION, SOLUTION, CONCENTRATE [REMEDYREPACK INC.] | 12 | Legacy NDC | 20250508_a9597463-896e-4fd4-bfd5-902f6736a54d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 5726eeca-db88-ba8e-e063-6294a90a927d | 2026-08-03 | Warnings, Adverse reactions | 205029 NDA205029 |
| Epinephrine | EPINEPHRINE | A-S Medication Solutions | 386519ba-7a44-4edd-9eb1-748419b7a71b | 2026-07-06 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | Henry Schein, Inc. | af10f2bb-b0ad-45a6-b525-e715613350af | 2026-01-13 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | BPI Labs, LLC | 7499cbca-b8fe-4fc3-a318-13859ab989a7 | 2025-12-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | BPI Labs, LLC | 3fd8dd51-0aeb-43dd-9de0-c11b0330b15e | 2025-12-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | BPI Labs, LLC | db18519b-82a9-435b-85c7-a040d644f057 | 2025-12-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| Epinephrine | EPINEPHRINE | BPI Labs, LLC | 5b5282a9-b149-4f0a-978e-5adbf48ec8aa | 2025-12-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| Epinephrine | EPINEPHRINE | ProPharma Distribution | 384445ac-0696-e367-e063-6394a90a019f | 2025-12-18 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | Medical Purchasing Solutions, LLC. | 409581e7-ab70-41f3-e063-6294a90a15dc | 2025-10-07 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | REMEDYREPACK INC. | 5ba14408-c8fb-4734-aad9-ee19696acac2 | 2025-09-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| Epinephrine | EPINEPHRINE | Medical Purchasing Solutions, LLC | 677c33a2-4e16-406e-e053-2991aa0a4594 | 2022-10-13 | Warnings, Adverse reactions | 205029 NDA205029 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-1215-0 | 70518121500 | 10 AMPULE in 1 BOX (70518-1215-0) > 1 mL in 1 AMPULE | 10 ampule | 2018-05-17 | 0000-00-00 | No | No | Current |